BridgeMD
New treatment option for Dysphagia
Official title The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
ClinicalTrials.gov ID: NCT07027826
What this study is testing
- What it's testing
- Background: Eosinophilic esophagitis (EoE) is a disease that causes inflammation in the esophagus. The esophagus is the tube that moves food from the mouth to the stomach.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Able to provide informed consent.
- Aged 18 to 65 years.
- Born in the African continent or their parents were born in Africa,
- Exhibiting symptoms of dysphagia and/or prior history of food impaction.
You likely can't join if
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Recent steroid use (systemic or swallowed/topical corticosteroid) within 4 weeks prior to endoscopy.
- Recent use of dupilumab (Dupixent) within the last 6 months.
- Recent use of other biologic medications (within either 6 months or 5 half-lives, whichever is longer). Examples of biologic medications include: 3a...
See the full eligibility criteria
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Able to provide informed consent.
- Aged 18 to 65 years.
- Born in the African continent or their parents were born in Africa,
- Exhibiting symptoms of dysphagia and/or prior history of food impaction.
- Undergoing clinically indicated endoscopy at the NIH Clinical Center (U.S.), Centre Hospitalier Universitaire Gabriel Tour(SqrRoot)(Copyright) (Mali), or other local clinics (Mali) and willing to provide research...
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Recent steroid use (systemic or swallowed/topical corticosteroid) within 4 weeks prior to endoscopy.
- Recent use of dupilumab (Dupixent) within the last 6 months.
- Recent use of other biologic medications (within either 6 months or 5 half-lives, whichever is longer). Examples of biologic medications include: 3a. mepolizumab (Nucala) 3b. reslizumab (Cinqair, Cinqaero) 3c...
The study team makes the final eligibility decision.
Where it's taking place
- Bethesda, Maryland, United States
- Bamako, Mali
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bethesda, Maryland, United States; Bamako, Mali. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.